Non-Hodgkin Lymphoma: Treatment
Non-Hodgkin Lymphoma: Treatment
Treatment for non-Hodgkin lymphoma often involves a combination of chemotherapy and radiation, but can vary depending on the stage at diagnosis.
- The treatment you get for non-Hodgkin lymphoma will depend on the type of lymphoma, the stage and the how fast it's growing
- Diffuse large B-cell lymphoma is the most common type diagnosed in the United States and worldwide
- People with aggressive non-Hodgkin lymphoma can expect to get a chemotherapy combination called R-CHOP
Treatment : Understanding the Options for Diffuse Large B-Cell Lymphoma
- The treatment you get for non-Hodgkin lymphoma will depend on the type of lymphoma, the stage and the how fast it’s growing
- Diffuse large B-cell lymphoma is the most common type diagnosed in the United States and worldwide
- People with aggressive non-Hodgkin lymphoma can expect to get a chemotherapy combination called R-CHOP
- R-CHOP is a drug cocktail commonly used to treat diffuse large B-cell non-Hodgkin lymphoma
- It consists of three chemotherapy drugs, plus an antibody drug and a steroid
- Doctors typically give R-CHOP in cycles that are 3 weeks apart, and most patients can expect at least 6 cycles
Treatment : Chemotherapy
- R-CHOP is a drug cocktail commonly used to treat diffuse large B-cell non-Hodgkin lymphoma
- It consists of three chemotherapy drugs, plus an antibody drug and a steroid
- Doctors typically give R-CHOP in cycles that are 3 weeks apart, and most patients can expect at least 6 cycles
- Radiation can be used for several different stages of non-Hodgkin lymphoma
- For patients with slow-growing disease, radiation may be the only treatment your doctor recommends
- For patients with larger or more aggressive non-Hodgkin lymphoma, radiation may be recommended after chemotherapy
Treatment : Radiation
- Radiation can be used for several different stages of non-Hodgkin lymphoma
- For patients with slow-growing disease, radiation may be the only treatment your doctor recommends
- For patients with larger or more aggressive non-Hodgkin lymphoma, radiation may be recommended after chemotherapy
- Children with non-Hodgkin lymphoma are typically given more aggressive chemotherapy because their bodies are generally able to tolerate it better
- Long-term survival in children with B-cell non-Hodgkin lymphoma is over 90%
Treatment : Treating Non-Hodgkin Lymphoma in Children
- Children with non-Hodgkin lymphoma are typically given more aggressive chemotherapy because their bodies are generally able to tolerate it better
- Long-term survival in children with B-cell non-Hodgkin lymphoma is over 90%
- Mantle cell lymphoma is a type of non-Hodgkin lymphoma
- The disease can be either slow-growing (indolent) or fast-growing (aggressive)
- Aggressive mantle cell lymphoma may be treated with a combination of a monoclonal antibody (rituximab) and chemotherapy
Treatment : Mantle Cell Lymphoma
- Mantle cell lymphoma is a type of non-Hodgkin lymphoma
- The disease can be either slow-growing (indolent) or fast-growing (aggressive)
- Aggressive mantle cell lymphoma may be treated with a combination of a monoclonal antibody (rituximab) and chemotherapy
Immunotherapy
Our immune system is designed to fight off harmful invaders, and that includes cancer. It uses proteins called antibodies to find and stick to the foreign cells, targeting them for destruction. But sometimes the immune system needs a little help finding and fighting lymphoma, which for some people can come in the form... Read More
Antibody Drug Conjugates
Brentuximab vedotin (Adcetris) is a new targeted treatment for non-Hodgkin lymphoma and Hodgkin lymphoma. It's helping to improve the outlook for people who haven't responded to their first treatment, or whose cancer has returned after treatment. It's also being used in some people who are newly diagnosed. Lymphoma... Read More